Stocks to buy

Stock: Piramal Pharma
Research House: JM Financial
Advice: Buy
Stock Price: Rs 249
1-year Target Price: Rs 340
Potential Upside: 36.5%
Comment: Initiate with ‘buy’ due to the strong growth prospects of its CDMO business, led by newly commercialised molecules and expected recovery in the US biotech sector. Also, its differentiated offerings, global manufacturing
presence and end-to-end capabilities are the key strongholds.